Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy and safety of maralixibat in infants with Biliary Atresia
(BA) after Hepatoportoenterostomy (HPE, also known as the Kasai procedure).